Do analysts prefer DMII or AGD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Drugs Made In America Acquisition II 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Abrdn Global Dynamic Dividend Fund 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, DMII or AGD?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Drugs Made In America Acquisition II N/A N/A N/A N/A N/A Abrdn Global Dynamic Dividend Fund $75.72M N/A N/A N/A N/A

Is DMII or AGD more profitable?

Company Net Margins Return on Equity Return on Assets Drugs Made In America Acquisition II N/A N/A N/A Abrdn Global Dynamic Dividend Fund N/A N/A N/A

Do analysts rate DMII or AWP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Drugs Made In America Acquisition II 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 abrdn Global Premier Properties Fund 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings & valuation, DMII or AWP?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Drugs Made In America Acquisition II N/A N/A N/A N/A N/A abrdn Global Premier Properties Fund $60.73M N/A N/A N/A N/A

Is DMII or AWP more profitable?

Company Net Margins Return on Equity Return on Assets Drugs Made In America Acquisition II N/A N/A N/A abrdn Global Premier Properties Fund N/A N/A N/A

Do analysts prefer THQ or DMII?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abrdn Healthcare Opportunities Fund 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Drugs Made In America Acquisition II 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, THQ or DMII?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Abrdn Healthcare Opportunities Fund -$28.02M N/A N/A N/A N/A Drugs Made In America Acquisition II N/A N/A N/A N/A N/A

Is THQ or DMII more profitable?

Company Net Margins Return on Equity Return on Assets Abrdn Healthcare Opportunities Fund N/A N/A N/A Drugs Made In America Acquisition II N/A N/A N/A

Do analysts recommend DMII or ACP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Drugs Made In America Acquisition II 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Abrdn Income Credit Strategies Fund 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings & valuation, DMII or ACP?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Drugs Made In America Acquisition II N/A N/A N/A N/A N/A Abrdn Income Credit Strategies Fund $85.32M N/A N/A N/A N/A

Is DMII or ACP more profitable?

Company Net Margins Return on Equity Return on Assets Drugs Made In America Acquisition II N/A N/A N/A Abrdn Income Credit Strategies Fund N/A N/A N/A

Do analysts rate THW or DMII?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abrdn World Healthcare Fund 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Drugs Made In America Acquisition II 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, THW or DMII?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Abrdn World Healthcare Fund $86.53M N/A N/A N/A N/A Drugs Made In America Acquisition II N/A N/A N/A N/A N/A

Is THW or DMII more profitable?

Company Net Margins Return on Equity Return on Assets Abrdn World Healthcare Fund N/A N/A N/A Drugs Made In America Acquisition II N/A N/A N/A

Drugs Made In America Acquisition II (DMII) Competitors

$10.18 +0.01 (+0.05%)

Closing price 03:59 PM Eastern

Extended Trading

$10.18 0.00 (0.00%)

As of 04:04 PM Eastern

Compare

DMII vs. AGD, AWP, THQ, ACP, and THW

Should you buy Drugs Made In America Acquisition II stock or one of its competitors? Drugs Made In America Acquisition II's main competitors and comparable companies include Abrdn Global Dynamic Dividend Fund (AGD), abrdn Global Premier Properties Fund (AWP), Abrdn Healthcare Opportunities Fund (THQ), Abrdn Income Credit Strategies Fund (ACP), and Abrdn World Healthcare Fund (THW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does Drugs Made In America Acquisition II compare to Abrdn Global Dynamic Dividend Fund?

Drugs Made In America Acquisition II (NASDAQ:DMII) and Abrdn Global Dynamic Dividend Fund (NYSE:AGD) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

In the previous week, Abrdn Global Dynamic Dividend Fund had 1 more articles in the media than Drugs Made In America Acquisition II. MarketBeat recorded 2 mentions for Abrdn Global Dynamic Dividend Fund and 1 mentions for Drugs Made In America Acquisition II. Drugs Made In America Acquisition II's average media sentiment score of 1.79 beat Abrdn Global Dynamic Dividend Fund's score of 0.92 indicating that Drugs Made In America Acquisition II is being referred to more favorably in the media.

Company	Overall Sentiment
Drugs Made In America Acquisition II	Very Positive
Abrdn Global Dynamic Dividend Fund	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Drugs Made In America Acquisition II	N/A	N/A	N/A	N/A	N/A
Abrdn Global Dynamic Dividend Fund	$75.72M	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Drugs Made In America Acquisition II	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Abrdn Global Dynamic Dividend Fund	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
Drugs Made In America Acquisition II	N/A	N/A	N/A
Abrdn Global Dynamic Dividend Fund	N/A	N/A	N/A

Summary

Drugs Made In America Acquisition II and Abrdn Global Dynamic Dividend Fund tied by winning 2 of the 4 factors compared between the two stocks.

How does Drugs Made In America Acquisition II compare to abrdn Global Premier Properties Fund?

Drugs Made In America Acquisition II (NASDAQ:DMII) and abrdn Global Premier Properties Fund (NYSE:AWP) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership and media sentiment.

Company	Net Margins	Return on Equity	Return on Assets
Drugs Made In America Acquisition II	N/A	N/A	N/A
abrdn Global Premier Properties Fund	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Drugs Made In America Acquisition II	N/A	N/A	N/A	N/A	N/A
abrdn Global Premier Properties Fund	$60.73M	N/A	N/A	N/A	N/A

In the previous week, Drugs Made In America Acquisition II and Drugs Made In America Acquisition II both had 1 articles in the media. Drugs Made In America Acquisition II's average media sentiment score of 1.79 beat abrdn Global Premier Properties Fund's score of 0.00 indicating that Drugs Made In America Acquisition II is being referred to more favorably in the media.

Company	Overall Sentiment
Drugs Made In America Acquisition II	Very Positive
abrdn Global Premier Properties Fund	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Drugs Made In America Acquisition II	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
abrdn Global Premier Properties Fund	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Drugs Made In America Acquisition II beats abrdn Global Premier Properties Fund on 2 of the 3 factors compared between the two stocks.

How does Drugs Made In America Acquisition II compare to Abrdn Healthcare Opportunities Fund?

Abrdn Healthcare Opportunities Fund (NYSE:THQ) and Drugs Made In America Acquisition II (NASDAQ:DMII) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

Company	Net Margins	Return on Equity	Return on Assets
Abrdn Healthcare Opportunities Fund	N/A	N/A	N/A
Drugs Made In America Acquisition II	N/A	N/A	N/A

In the previous week, Abrdn Healthcare Opportunities Fund and Abrdn Healthcare Opportunities Fund both had 1 articles in the media. Drugs Made In America Acquisition II's average media sentiment score of 1.79 beat Abrdn Healthcare Opportunities Fund's score of -1.45 indicating that Drugs Made In America Acquisition II is being referred to more favorably in the news media.

Company	Overall Sentiment
Abrdn Healthcare Opportunities Fund	Negative
Drugs Made In America Acquisition II	Very Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abrdn Healthcare Opportunities Fund	-$28.02M	N/A	N/A	N/A	N/A
Drugs Made In America Acquisition II	N/A	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abrdn Healthcare Opportunities Fund	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Drugs Made In America Acquisition II	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Drugs Made In America Acquisition II beats Abrdn Healthcare Opportunities Fund on 3 of the 3 factors compared between the two stocks.

How does Drugs Made In America Acquisition II compare to Abrdn Income Credit Strategies Fund?

Drugs Made In America Acquisition II (NASDAQ:DMII) and Abrdn Income Credit Strategies Fund (NYSE:ACP) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, media sentiment, analyst recommendations, institutional ownership and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Drugs Made In America Acquisition II	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Abrdn Income Credit Strategies Fund	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
Drugs Made In America Acquisition II	N/A	N/A	N/A
Abrdn Income Credit Strategies Fund	N/A	N/A	N/A

In the previous week, Drugs Made In America Acquisition II and Drugs Made In America Acquisition II both had 1 articles in the media. Drugs Made In America Acquisition II's average media sentiment score of 1.79 beat Abrdn Income Credit Strategies Fund's score of 1.00 indicating that Drugs Made In America Acquisition II is being referred to more favorably in the media.

Company	Overall Sentiment
Drugs Made In America Acquisition II	Very Positive
Abrdn Income Credit Strategies Fund	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Drugs Made In America Acquisition II	N/A	N/A	N/A	N/A	N/A
Abrdn Income Credit Strategies Fund	$85.32M	N/A	N/A	N/A	N/A

Summary

Drugs Made In America Acquisition II beats Abrdn Income Credit Strategies Fund on 2 of the 3 factors compared between the two stocks.

How does Drugs Made In America Acquisition II compare to Abrdn World Healthcare Fund?

Abrdn World Healthcare Fund (NYSE:THW) and Drugs Made In America Acquisition II (NASDAQ:DMII) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

Company	Net Margins	Return on Equity	Return on Assets
Abrdn World Healthcare Fund	N/A	N/A	N/A
Drugs Made In America Acquisition II	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abrdn World Healthcare Fund	$86.53M	N/A	N/A	N/A	N/A
Drugs Made In America Acquisition II	N/A	N/A	N/A	N/A	N/A

In the previous week, Abrdn World Healthcare Fund had 1 more articles in the media than Drugs Made In America Acquisition II. MarketBeat recorded 2 mentions for Abrdn World Healthcare Fund and 1 mentions for Drugs Made In America Acquisition II. Drugs Made In America Acquisition II's average media sentiment score of 1.79 beat Abrdn World Healthcare Fund's score of -0.01 indicating that Drugs Made In America Acquisition II is being referred to more favorably in the news media.

Company	Overall Sentiment
Abrdn World Healthcare Fund	Neutral
Drugs Made In America Acquisition II	Very Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abrdn World Healthcare Fund	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Drugs Made In America Acquisition II	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Abrdn World Healthcare Fund and Drugs Made In America Acquisition II tied by winning 2 of the 4 factors compared between the two stocks.

Get Drugs Made In America Acquisition II News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DMII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DMII vs. The Competition

Export

Metric	Drugs Made In America Acquisition II	Capital Markets Industry	Finance Sector	NASDAQ Exchange
Market Cap	N/A	$5.16B	$13.40B	$13.08B
Dividend Yield	N/A	7.51%	5.99%	14.19%
P/E Ratio	N/A	29.88	24.68	25.72
Price / Sales	N/A	1,187.93	507.73	97.42
Price / Cash	N/A	47.83	50.23	52.35
Price / Book	N/A	3.49	2.69	6.31
Net Income	N/A	$417.69M	$1.32B	$360.55M
7 Day Performance	0.25%	-0.95%	-1.04%	-1.75%
1 Month Performance	0.44%	4.77%	0.80%	-4.26%
1 Year Performance	N/A	3.82%	8.16%	3.68%

Drugs Made In America Acquisition II Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DMII Drugs Made In America Acquisition II	N/A	$10.19 +0.0%	N/A	N/A	$0.00	N/A	N/A	2	Positive News
AGD Abrdn Global Dynamic Dividend Fund	N/A	$11.85 +0.0%	N/A	-11.0%	$0.00	$75.72M	N/A	N/A	News Coverage Positive News Short Interest Decrease
AWP abrdn Global Premier Properties Fund	N/A	$10.65 -0.4%	N/A	-10.6%	$0.00	$60.73M	N/A	N/A	News Coverage Positive News
THQ Abrdn Healthcare Opportunities Fund	N/A	$18.78 -0.4%	N/A	+8.6%	$0.00	-$28.02M	N/A	1,088
ACP Abrdn Income Credit Strategies Fund	N/A	$4.46 -1.0%	N/A	-22.4%	$0.00	$85.32M	N/A	N/A	Positive News Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DMII) was last updated on 9/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Drugs Made In America Acquisition II (DMII) Competitors

DMII vs. AGD, AWP, THQ, ACP, and THW

How does Drugs Made In America Acquisition II compare to Abrdn Global Dynamic Dividend Fund?

Summary

How does Drugs Made In America Acquisition II compare to abrdn Global Premier Properties Fund?

Summary

How does Drugs Made In America Acquisition II compare to Abrdn Healthcare Opportunities Fund?

Summary

How does Drugs Made In America Acquisition II compare to Abrdn Income Credit Strategies Fund?

Summary

How does Drugs Made In America Acquisition II compare to Abrdn World Healthcare Fund?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DMII vs. The Competition

Drugs Made In America Acquisition II Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Drugs Made In America Acquisition II (DMII) Competitors

DMII vs. AGD, AWP, THQ, ACP, and THW

How does Drugs Made In America Acquisition II compare to Abrdn Global Dynamic Dividend Fund?

Does the media favor DMII or AGD?

Which has preferable valuation and earnings, DMII or AGD?

Do analysts prefer DMII or AGD?

Is DMII or AGD more profitable?

Summary

How does Drugs Made In America Acquisition II compare to abrdn Global Premier Properties Fund?

Is DMII or AWP more profitable?

Which has stronger earnings & valuation, DMII or AWP?

Does the media prefer DMII or AWP?

Do analysts rate DMII or AWP?

Summary

How does Drugs Made In America Acquisition II compare to Abrdn Healthcare Opportunities Fund?

Is THQ or DMII more profitable?

Does the media refer more to THQ or DMII?

Which has stronger earnings & valuation, THQ or DMII?

Do analysts prefer THQ or DMII?

Summary

How does Drugs Made In America Acquisition II compare to Abrdn Income Credit Strategies Fund?

Do analysts recommend DMII or ACP?

Is DMII or ACP more profitable?

Does the media prefer DMII or ACP?

Which has preferable earnings & valuation, DMII or ACP?

Summary

How does Drugs Made In America Acquisition II compare to Abrdn World Healthcare Fund?

Is THW or DMII more profitable?

Which has higher earnings and valuation, THW or DMII?

Does the media favor THW or DMII?

Do analysts rate THW or DMII?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DMII vs. The Competition

Drugs Made In America Acquisition II Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools